Prescribing unproven cancer drugs: physician perspectives on expanded access and right to try
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Law and the Biosciences"
DOI: 10.1093/jlb/lsac031
Abstract: Abstract Background For gravely ill patients who have no treatment options and who are ineligible for clinical trials, the US Food and Drug Administration (FDA) established the Expanded Access Program (EAP). Motivated by efforts to… read more here.
Keywords: right try; prescribing unproven; expanded access; unproven cancer ... See more keywords